急性缺血性卒中串联闭塞患者的颈动脉支架置入与机械取栓:抗血栓治疗与功能预后
多中心回顾性研究纳入95例前循环串联闭塞行颈动脉支架置入联合机械取栓患者,3个月良好功能预后(mRS≤2)见于33例(39.3%)。基线ASPECTS≥8、取栓尝试≤2次及无症状性颅内出血与良好预后相关;术中肝素剂量较高、ASPECTS≤7及取栓尝试≥3次与症状性颅内出血相关。抗血小板药物使用安全,双重抗血小板治疗与更好的功能预后相关。
要点
- 基线ASPECTS≥8与良好功能预后独立相关(OR=1.53),ASPECTS≤7时症状性颅内出血风险升高。
- 取栓尝试≤2次与良好预后相关(OR=0.71),≥3次尝试与症状性颅内出血相关。
- 术中肝素剂量较高(≥3000 IU)在初始ASPECTS≤7时增加症状性颅内出血风险。
诊断标准与关键数值
- 良好临床预后定义为3个月mRS≤2,95例中33例(39.3%)达到。
- 良好预后与基线ASPECTS≥8相关(OR=1.53;95%CI 1.16-2.00)。
- 良好预后与机械取栓尝试≤2次相关(OR=0.71;95%CI 0.55-0.99)。
- 良好预后与无症状性颅内出血相关(OR=0.13;95%CI 0.03-0.51)。
- 症状性颅内出血与较高的术中肝素剂量、ASPECTS≤7及机械取栓尝试≥3次相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: There is no consensus on the optimal antithrombotic medication for patients with acute ischemic stroke with anterior circulation tandem occlusions treated with emergent carotid stent placement and mechanical thrombectomy. The identification of factors influencing hemorrhagic risks can assist in creating appropriate therapeutic algorithms for such patients. This study aimed to investigate the impact of medical therapy on functional and safety outcomes in patients treated with carotid stent placement and mechanical thrombectomy for tandem occlusions.
MATERIALS AND METHODS: A multicenter retrospective study on prospectively collected data was conducted. Only patients treated with carotid stent placement and mechanical thrombectomy for tandem occlusions of the anterior circulation were included. Univariate and multivariate analyses were performed on preprocedural, procedural, and postprocedural variables to assess factors influencing clinical outcome, symptomatic intracranial hemorrhage, stent patency, and successful intracranial vessel recanalization.
RESULTS: Ninety-five patients with acute ischemic stroke and tandem occlusions were included. Good clinical outcome (mRS ≤ 2) at 3 months was reached by 33 (39.3%) patients and was associated with baseline ASPECTS ≥ 8 (OR = 1.53; 95% CI, 1.16-2.00), ≤2 mechanical thrombectomy attempts (OR = 0.71; 95% CI, 0.55-0.99), and the absence of symptomatic intracranial hemorrhage (OR = 0.13; 95% CI , 0.03-0.51). Symptomatic intracranial hemorrhage was associated with a higher amount of intraprocedural heparin, ASPECTS ≤ 7, and ≥3 mechanical thrombectomy attempts. No relationships among types of acute antiplatelet regimen, intravenous thrombolysis, and symptomatic intracranial hemorrhage were observed. Patients receiving dual-antiplatelet therapy after hemorrhagic transformation had been ruled out on 24-hour CT were more likely to achieve functional independence and had a lower risk of symptomatic intracranial hemorrhage.
CONCLUSIONS: During carotid stent placement and mechanical thrombectomy for tandem occlusion treatment, higher intraprocedural heparin dosage (≥3000 IU) increased symptomatic intracranial hemorrhage risk when the initial ASPECTS was ≤7, and mechanical thrombectomy needs more than one passage for complete recanalization. Antiplatelets antiplatelets use were safe, and dual-antiaggregation therapy was related to better functional outcomes.
引用
- Da Ros V, Scaggiante J, Sallustio F, et al. Carotid Stenting and Mechanical Thrombectomy in Patients with Acute Ischemic Stroke and Tandem Occlusions: Antithrombotic Treatment and Functional Outcome. AJNR Am J Neuroradiol. 2020. PMID: 32972953. doi:10.3174/ajnr.A6768
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。